½ÃÀ庸°í¼­
»óǰÄÚµå
1715168

À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¿¹Ãø(-2031³â) : Áö¿ªº° ºÐ¼®(Á¦Ç°º°, ÀûÀÀÁõº°, Ä«Å×°í¸®º°, ½Ã½ºÅÛ À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°)

Europe Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product, Indication, Category, System Type, and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 111 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº 2023³â 7¾ï 9,179¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â¿¡´Â 11¾ï 2,179¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁö CAGR 4.5%·Î ÃßÁ¤µË´Ï´Ù.

ÀÏȸ¿ë Ä«Å×ÅÍ Ã¤ÅÃÀº À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀ» °ßÀÎ

ÀÏȸ¿ë °£Çæ Ä«Å×ÅÍ´Â ¿ä·Î °¨¿°(UTI)ÀÇ À§Çè °¨¼Ò, ¿äµµ ¿Ü»ó ¹× QOL°ú °°Àº °Ç°­ °á°úÀÇ °³¼±°ú °ü·ÃµÇ¾î ÀÖ½À´Ï´Ù. ÀÏȸ¿ë °£Çæ Ä«Å×ÅÍ´Â ¿ä·Î°á¼®À» ¹Ýº¹Çϴ ȯÀÚ¿¡°Ô °­·ÂÈ÷ ±ÇÀåµË´Ï´Ù. ¶ÇÇÑ, »ç¿ë»óÀÇ Æí¸®¼ºÀ¸·ÎºÎÅÍ ¸¹Àº ȯÀÚ¿¡°Ô ¼±È£µÇ°í ÀÖ½À´Ï´Ù. BMJ Open(ÀÇÇÐ ÀâÁö)¿¡ °ÔÀçµÈ ³í¹®¿¡ ÀÇÇϸé, °£ÇæÀû Ä«Å×ÅÍ À¯Ä¡¸¦ À§ÇÑ Ä«Å×ÅÍ »ç¿ë·üÀº Áö¿ª¿¡ µû¶ó ´Ù¸£¸ç, ±× ±âÈ£´Â Á¾Á¾ °æÁ¦Àû Á¶°Ç¿¡ ÀÇÇØ µ¿±â ºÎ¿©µÇ°í ÀÖ½À´Ï´Ù. ¾î¶² À¯·´ ±¹°¡¿¡¼­´Â °ÅÀÇ ¸ðµç ȯÀÚ°¡ ÀÏȸ¿ë Ä«Å×Å͸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ±× ¶§¹®¿¡ °¨¿°ÀÇ °¡´É¼ºÀÌ ³·°í, ¸ê±Õ ¹× À±È° ´ëÃ¥ÀÌ ¶Ù¾î³­ ÀÏȸ¿ëÇü °£Çæ Ä«Å×ÅÍÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ºÆ®·¹ÀÌÆ® Ĩ, ¼¿ÇÁij½º ¼Ò¾Æ¿ë, ¼¿ÇÁij½º ¿©¼º¿ë µîÀÇ ÀÏȸ¿ë Ä«Å×Å͸¦ Á¦°øÇϰí ÀÏȸ¿ë °£Çæ Ä«Å×ÅÍÀÇ Ã¤¿ë Áõ°¡°¡ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå °³¿ä

µ¶ÀÏ¿¡¼­´Â Àü¸³¼±¾ÏÀÇ ÀÌȯÀ²ÀÌ ³ôÀº °ÍÀÌ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀåÀÇ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¾ÏÀÇ ±¹Á¦Á¶»ç±â°üÀÎ Globocan 2020¿¡ µû¸£¸é µ¶ÀÏ¿¡¼­ Àü¸³¼±¾ÏÀÇ ÀÌȯÀ²Àº 2020³â¿¡´Â Àα¸ 10¸¸¸í´ç 66¸íÀÌ µÈ´Ù°í º¸°íµÇ¾ú½À´Ï´Ù. ³ôÀº ÀÌȯÀ²ÀÌ Æú¸® Ä«Å×ÅÍ¿Í °°Àº Ä¡·á Àåºñ¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁö±â ¶§¹®ÀÏ ¼ö ÀÖ½À´Ï´Ù.

À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¼öÀͰú 2031³â±îÁö ¿¹Ãø(±Ý¾× ±âÁØ)

À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¼¼ºÐÈ­

À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº Á¦Ç°, ÀûÀÀÁõ, Ä«Å×°í¸®, ½Ã½ºÅÛ À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç°º°·Î À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ¿Í ºñÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ·Î À̺е˴ϴÙ. 2023³â À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼­´Â ÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ ºÎ¹®ÀÌ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÀûÀÀÁõ¿¡¼­ À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ¿ä½Ç±Ý, ÀÏ¹Ý ¼ö¼ú, ô¼ö ¼Õ»ó, ÆÄŲ½¼ º´(PD), ´Ù¹ß¼º °æÈ­Áõ µîÀ¸·Î ºÐ·ùµË´Ï´Ù. 2023³â À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼­´Â ¿ä½Ç±Ý ºÐ¾ß°¡ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Ä«Å×°í¸®º°·Î º¸¸é À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ¿©¼º¿ë Ä«Å×ÅÍ, ³²¼º¿ë Ä«Å×ÅÍ, ¾Æµ¿¿ë Ä«Å×ÅÍ·Î ºÐ·ùµË´Ï´Ù. 2023³â À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ ¿©¼º¿ë Ä«Å×ÅÍ ºÎ¹®Àº ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

½Ã½ºÅÛ À¯Çüº°·Î À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº Æó¼âÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛ°ú °³¹æÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛÀ¸·Î ³ª´¹´Ï´Ù. 2023³â À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼­´Â Æó¼âÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛ ºÎ¹®ÀÌ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅÃÄ¡·á µîÀ¸·Î ±¸ºÐµË´Ï´Ù.

±¹°¡º°·Î À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ ¹× ±âŸ À¯·´À¸·Î ³ª´µ¾îÁ® ÀÖ½À´Ï´Ù.

Advin Health Care Pvt Ltd, B Braun SE, Boston Scientific Corp, Cardinal Health Inc, Coloplast Corp, Convatec Group Plc, Medical Technologies of Georgia, Inc, Teleflex Inc, Wellspect HealthCare´Â À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®
  • ½ÃÀåÀÇ ¸Å·Â

Á¦3Àå ºÐ¼® ¹æ¹ý

  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç
    • °¡¼³ÀÇ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀκм®
    • ±âÃÊ ¼öÄ¡ÀÇ °³¹ß
    • µ¥ÀÌÅÍÀÇ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ

Á¦5Àå À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¿ä½Ç±ÝÀÇ ±ÞÁõ
    • ÀÏȸ¿ë Ä«Å×ÅÍ Ã¤¿ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ä«Å×ÅÍ Ä¡·á¿¡ µû¸¥ ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • ÀÚ±â Ä«Å×ÅÍ Ä¡·áÀÇ Àαâ¿Í ¿äµµ Ä«Å×ÅÍ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ¾×
  • ÇâÈÄÀÇ µ¿Çâ
    • ¸¶ÀÌÅ©·ÎȦ Á¸ Ä«Å×ÅÍ
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦5Àå À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå : À¯·´ ½ÃÀå ºÐ¼®

  • À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¼öÀÍ(2021-2031³â)
  • °³¿ä

Á¦6Àå À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • °³¿ä
  • ÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ
  • ºñÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ

Á¦7Àå À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

  • °³¿ä
  • ¿ä½Ç±Ý
  • ÀÏ¹Ý ¿Ü°ú
  • ô¼ö ¼Õ»ó
  • ÆÄŲ½¼º´(PD)
  • ´Ù¹ß¼º °æÈ­Áõ
  • ±âŸ

Á¦8Àå À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : Ä«Å×°í¸®º°

  • °³¿ä
  • ¿©¼º¿ë Ä«Å×ÅÍ
  • ³²¼º¿ë Ä«Å×ÅÍ
  • ¾Æµ¿¿ë Ä«Å×ÅÍ

Á¦9Àå À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : ½Ã½ºÅÛ À¯Çüº°

  • °³¿ä
  • Æó¼âÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛ
  • °³¹æÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛ

Á¦10Àå À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ÀçÅÃÄ¡·á
  • ±âŸ

Á¦11Àå À¯·´ÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå : ±¹°¡º° ºÐ¼®

  • µ¶ÀÏ
  • ¿µ±¹
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ±âŸ À¯·´

Á¦12Àå °£Çæ Ä«Å×ÅÍ ½ÃÀå : ¾÷°è Á¤¼¼

  • °³¿ä
  • °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ÀÇ ¼ºÀå Àü·«

Á¦13Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Coloplast Corp
  • Boston Scientific Corp
  • Hollister Inc
  • Teleflex Inc
  • Convatec Group Plc
  • B Braun SE
  • Cardinal Health Inc
  • Medical Technologies of Georgia, Inc.
  • Wellspect HealthCare

Á¦14Àå ºÎ·Ï

JHS 25.05.15

The Europe intermittent catheters market was valued at US$ 791.79 million in 2023 and is expected to reach US$ 1,121.79 million by 2031; it is estimated to register a CAGR of 4.5% from 2023 to 2031.

Adoption of Single-Use Catheters Drives Europe Intermittent Catheters Market

Single-use intermittent catheters have been linked with improved health outcomes, including a lower risk of urinary tract infections (UTIs), urethral trauma, and quality of life. The use of single-use catheters for intermittent catheterization reduces the risk of short and long-term problems. Single-use intermittent catheters are highly recommended for patients with recurring UTIs. Moreover, they are a preferred option in many patients due to the convenience of use. Modern single-use catheters are designed to be inserted with proper safety and sterility measures using applicators, or they may be offered with an extra protective coating. According to an article published by BMJ Open (a medical journal), the incidence of using catheters for intermittent catheterization varies in different regions, and the preference is frequently motivated by financial conditions. In most European countries, almost every patient uses a single-use catheter. Further, there are no regulatory foundations or evidence-based outcomes available that recommend the reuse or multiple use of catheters for intermittent catheterization. Thus, the adoption of single-use intermittent catheters is on the rise due to the reduced possibility of infections, and better sterility and lubrication measures. For instance, Coloplast offers Self-Cath Male, straight tip, Self-Cath Pediatric, Self-Cath Female, and other single use catheters, Thus, the rising adoption of single-use intermittent catheters drives the growth of the intermittent catheters market.

Europe Intermittent Catheters Market Overview

The high incidence of prostate cancer in Germany is responsible for the growth of the intermittent catheters market. For instance, according to Globocan 2020, an international agency for research on cancer, the prevalence rate of prostate cancer in Germany was reported to be 66 per 100,000 people in 2020. The high incidence rate can be attributed to the rising need for treatment equipment such as Foley catheters.

Europe Intermittent Catheters Market Revenue and Forecast to 2031 (US$ Million)

Europe Intermittent Catheters Market Segmentation

The Europe intermittent catheters market is categorized into product, indication, category, system type, end user, and country.

By product, the Europe intermittent catheters market is bifurcated into coated intermittent catheters and uncoated intermittent catheters. The coated intermittent catheters segment held a larger share of the Europe intermittent catheters market share in 2023.

In terms of indication, the Europe intermittent catheters market is segmented into urinary incontinence, general surgeries, spinal cord injuries, Parkinson's Disease (PD), multiple sclerosis, and others. The urinary incontinence segment held the largest share of the Europe intermittent catheters market share in 2023.

Based on category, the Europe intermittent catheters market is female length catheters, male length catheters, and kid length catheters. The female length catheters segment held the largest share of the Europe intermittent catheters market share in 2023.

By system type, the Europe intermittent catheters market is bifurcated into closed intermittent catheters systems and open intermittent catheters systems. The closed intermittent catheters systems segment held a larger share of the Europe intermittent catheters market share in 2023.

In terms of end user, the Europe intermittent catheters market is segmented into hospitals, ambulatory surgical centers, home care settings, and others. The hospitals segment held the largest share of the Europe intermittent catheters market share in 2023.

Based on country, the Europe intermittent catheters market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe intermittent catheters market in 2023.

Advin Health Care Pvt Ltd; B Braun SE; Boston Scientific Corp; Cardinal Health Inc; Coloplast Corp; Convatec Group Plc; Medical Technologies of Georgia, Inc.; Teleflex Inc; and Wellspect HealthCare are some of the leading companies operating in the Europe intermittent catheters market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Intermittent Catheters Market - Key Market Dynamics

  • 4.1 Europe Intermittent Catheters Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Surging Prevalence of Urinary Incontinence
    • 4.2.2 Adoption of Single-Use Catheters
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated with Catheterization
  • 4.4 Market Opportunities
    • 4.4.1 Growing Preference for Self-Catheterization and Increasing Investments in Urinary Catheter Developments
  • 4.5 Future Trends
    • 4.5.1 Micro-Hole Zone Catheters
  • 4.6 Impact of Drivers and Restraints:

5. Europe Intermittent Catheters Market - Europe Analysis

  • 5.1 Europe Intermittent Catheters Market Revenue (US$ Million), 2021-2031
    • 5.1.1 Overview

6. Europe Intermittent Catheters Market Analysis - by Product

  • 6.1 Overview
  • 6.2 Coated Intermittent Catheters
    • 6.2.1 Overview
    • 6.2.2 Coated Intermittent Catheters: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Uncoated Intermittent Catheters
    • 6.3.1 Overview
    • 6.3.2 Uncoated Intermittent Catheters: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Intermittent Catheters Market Analysis - by Indication

  • 7.1 Overview
  • 7.2 Urinary Incontinence
    • 7.2.1 Overview
    • 7.2.2 Urinary Incontinence: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 General surgery
    • 7.3.1 Overview
    • 7.3.2 General surgery: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Spinal cord injuries
    • 7.4.1 Overview
    • 7.4.2 Spinal cord injuries: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Parkinson Disease (PD)
    • 7.5.1 Overview
    • 7.5.2 Parkinson disease (PD): Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Multiple Sclerosis
    • 7.6.1 Overview
    • 7.6.2 Multiple Sclerosis: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Intermittent Catheters Market Analysis - by Category

  • 8.1 Overview
  • 8.2 Female Length Catheters
    • 8.2.1 Overview
    • 8.2.2 Female Length Catheters: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Male Length Catheters
    • 8.3.1 Overview
    • 8.3.2 Male Length Catheters: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Kid Length Catheters
    • 8.4.1 Overview
    • 8.4.2 Kid Length Catheters: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Intermittent Catheters Market Analysis - by System Type

  • 9.1 Overview
  • 9.2 Closed Intermittent Catheters Systems
    • 9.2.1 Overview
    • 9.2.2 Closed Intermittent Catheters Systems: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Open Intermittent Catheters Systems
    • 9.3.1 Overview
    • 9.3.2 Open Intermittent Catheters Systems: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Intermittent Catheters Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals
    • 10.2.1 Overview
    • 10.2.2 Hospitals: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Ambulatory Surgical Centers
    • 10.3.1 Overview
    • 10.3.2 Ambulatory Surgical Centers: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Home Care Settings
    • 10.4.1 Overview
    • 10.4.2 Home Care Settings: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Europe Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Intermittent Catheters Market - Country Analysis

  • 11.1 Europe Intermittent Catheters Market
    • 11.1.1 Europe Intermittent Catheters Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Germany: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.1 Overview
      • 11.1.1.2 Germany: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.2.1 Germany: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.2.2 Germany: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.2.3 Germany: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.2.4 Germany: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.2.5 Germany: Intermittent Catheters Market Breakdown, by End User
      • 11.1.1.3 United Kingdom: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 Overview
      • 11.1.1.4 United Kingdom: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.4.1 United Kingdom: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.4.2 United Kingdom: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.4.3 United Kingdom: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.4.4 United Kingdom: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.4.5 United Kingdom: Intermittent Catheters Market Breakdown, by End User
      • 11.1.1.5 France: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Overview
      • 11.1.1.6 France: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.6.1 France: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.6.2 France: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.6.3 France: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.6.4 France: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.6.5 France: Intermittent Catheters Market Breakdown, by End User
      • 11.1.1.7 Italy: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 Overview
      • 11.1.1.8 Italy: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.8.1 Italy: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.8.2 Italy: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.8.3 Italy: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.8.4 Italy: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.8.5 Italy: Intermittent Catheters Market Breakdown, by End User
      • 11.1.1.9 Spain: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.9.1 Overview
      • 11.1.1.10 Spain: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.10.1 Spain: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.10.2 Spain: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.10.3 Spain: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.10.4 Spain: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.10.5 Spain: Intermittent Catheters Market Breakdown, by End User
      • 11.1.1.11 Rest of Europe: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.11.1 Overview
      • 11.1.1.12 Rest of Europe: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.12.1 Rest of Europe: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.12.2 Rest of Europe: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.12.3 Rest of Europe: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.12.4 Rest of Europe: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.12.5 Rest of Europe: Intermittent Catheters Market Breakdown, by End User

12. Intermittent Catheters Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Intermittent Catheters Market

13. Company Profiles

  • 13.1 Coloplast Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Boston Scientific Corp
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Hollister Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Teleflex Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Convatec Group Plc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 B Braun SE
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Cardinal Health Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Medical Technologies of Georgia, Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Wellspect HealthCare
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦